市場調査レポート

商品コード

1609967

血漿分画の市場規模、シェア、動向分析レポート：製品別、方法別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2024年11月11日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

血漿分画市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、血漿分画の世界市場規模は2030年までに582億4,000万米ドルに達すると推定され、2025年から2030年にかけて8.5%のCAGRで成長すると予測されています。

市場成長を促進する主な要因は、世界の呼吸器疾患の有病率の上昇、血液関連疾患、様々な希少疾患に罹患しやすい高齢化です。これらは市場拡大の主な要因です。さらに、血漿療法や誘導体を必要とする希少疾患の有病率の上昇も市場成長を補完しています。

また、免疫グロブリンやα-1-抗トリプシンが世界中のさまざまな研究分野で使用されるようになったことも、世界市場の拡大に寄与しています。市場拡大のもう一つの重要な要因は、世界の採血施設の増加です。例えば、WHOによると、2022年5月現在、世界中で1億1,800万人以上の献血が行われ、血漿供給量が徐々に増加しています。さらに、血漿由来製品の使用に関する国民の意識を高めるための政府の支援策も、世界市場拡大の主要な促進要因となっています。

血漿輸血はCOVID-19感染の最先端治療のひとつです。例えば、2020年8月、米国食品医薬品局（USFDA）はCOVID-19の回復期血漿治療に緊急使用承認（EUA）を与えました。さらに2021年2月には、COVID-19の血漿EUAに関する改正指令を発表しました。その結果、COVID-19パンデミックの間、血漿分画技術の使用は増加すると予測されます。

個別化治療薬に対する需要の高まりにより研究開発費が増加しており、免疫血清グロブリンなどの血漿成分の技術的進歩は、高収率、低コスト、高速スループットなどの利点を有しており、市場成長の原動力となっています。一方、血漿から生成される免疫グロブリンは、自己免疫疾患や炎症性疾患を含む様々な臨床症状に対してより頻繁に使用されるようになっています。セルロプラスミン、IgA、プラスミンなどの治療薬は、血漿分画分野から多額の資金を得ています。さらに、タンパク質を分画するための効率的で安価な方法をもたらす技術革新や技術開発への投資が活発化していることも、この業界を後押ししています。

市場関連ビジネスを展開する企業にとって、この市場は多くの機会を提供してくれます。また、世界および各地域の市場参入企業は、市場が順調に拡大していることから、有機的・無機的開発戦略を積極的に実施しています。その結果、同市場は予測期間中にさらに注目すべき投資を呼び込むと予想されます。例えば、2022年1月、チェコ共和国で8番目の血漿採取施設がBiotest AGによって開設されました。国の公衆衛生当局であるSUKLは、同社にこれらのセンターの営業許可を与えました。

血漿分画市場レポートハイライト

免疫グロブリンセグメントは、2024年の収益シェアで63.2%と市場を独占し、CAGR 9.1%と最速の成長が見込まれます。
クロマトグラフィー部門が市場を独占し、2024年のシェアは33.7％でした。血漿分画のための精製技術だけでなく、工業規模のクロマトグラフィー分画の利用が最近増加しています。
神経分野は、神経疾患に対する血漿由来療法の認知度向上が牽引し、2024年に30.0%の最大売上シェアを占めました。多発性硬化症、ギラン・バレー症候群、慢性炎症性脱髄性多発神経炎などの疾患は、免疫グロブリン静注療法（IVIg）やプラズマフェレーシスなどの療法で治療されるようになってきています。
病院と診療所は、2024年の収益シェア53.4%で市場を独占し、予測期間中最も速いCAGR 9.0%で成長すると予想されます。この背景には、さまざまな医療用途における血漿由来療法の需要増加があります。

セグメントダッシュボード
世界の血漿分画市場製品変動分析
世界の血漿分画市場の規模と動向分析、製品別、2018～2030年
アルブミン
免疫グロブリン
- 静脈内免疫グロブリン
- 皮下免疫グロブリン
- その他の免疫グロブリン
凝固因子
- 第VIII因子
- 第IX因子
- フォン・ヴィレブランド因子
- プロトロンビン複合体濃縮物
- フィブリノゲン濃縮物
- その他
プロテアーゼ阻害剤
その他

第5章血漿分画市場：方法別推定・動向分析

セグメントダッシュボード
世界の血漿分画法市場変動分析
世界の血漿分画市場の規模と動向分析、方法別、2018～2030年
遠心分離
深層ろ過
クロマトグラフィー
その他

第6章血漿分画市場：用途別推定・動向分析

セグメントダッシュボード
世界の血漿分画市場の用途変動分析
世界の血漿分画市場の規模と動向分析、用途別、2018～2030年
神経学
血液学
腫瘍学
免疫学
呼吸器科
その他

第7章血漿分画市場：最終用途別推定・動向分析

セグメントダッシュボード
世界の血漿分画市場の最終用途変動分析
世界の血漿分画市場の規模と動向分析、最終用途別、2018～2030年
病院・クリニック
臨床調査
その他

第8章血漿分画市場：地域別推定・動向分析

地域別市場シェア分析、2024年および2030年
地域市場ダッシュボード
市場規模と予測動向分析、2018年から2030年：
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

企業/競合の分類
戦略マッピング
企業市況分析、2024年
企業プロファイル
- Grifols SA
- CSL Limited
- Takeda Pharmaceutical Company Limited
- Octapharma AG
- Kedrion SpA
- LFB SA
- Biotest AG
- Sanquin
- Bio Products Laboratory Ltd.
- Intas Pharmaceuticals Ltd

図表

List of Tables

Table 1 List of abbreviation
Table 2 Global plasma fractionation market, by region, 2018 - 2030 (USD Billion)
Table 3 Global plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 4 Global plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 5 Global plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 6 Global plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 7 North America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
Table 8 North America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 9 North America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 10 North America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 11 North America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 12 U.S. plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 13 U.S. plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 14 U.S. plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 15 U.S. plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 16 Canada plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 17 Canada plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 18 Canada plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 19 Canada plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 20 Mexico plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 21 Mexico plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 22 Mexico plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 23 Mexico plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 24 Europe plasma fractionation market, by country, 2018 - 2030 (USD Billion)
Table 25 Europe plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 26 Europe plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 27 Europe plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 28 Europe plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 29 UK plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 30 UK plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 31 UK plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 32 UK plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 33 Germany plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 34 Germany plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 35 Germany plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 36 Germany plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 37 France plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 38 France plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 39 France plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 40 France plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Italy plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 42 Italy plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 43 Italy plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 44 Italy plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 45 Spain plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 46 Spain plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 47 Spain plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 48 Spain plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 49 Denmark plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 50 Denmark plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 51 Denmark plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 52 Denmark plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 53 Sweden plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 54 Sweden plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 55 Sweden plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 56 Sweden plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 57 Norway plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 58 Norway plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 59 Norway plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 60 Norway plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 61 Asia Pacific plasma fractionation market, by country, 2018 - 2030 (USD Billion)
Table 62 Asia Pacific plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 63 Asia Pacific plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 64 Asia Pacific plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 65 Asia Pacific plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 66 Japan plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 67 Japan plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 68 Japan plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 69 Japan plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 70 China plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 71 China plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 72 China plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 73 China plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 74 India plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 75 India plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 76 India plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 77 India plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 78 Australia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 79 Australia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 80 Australia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 81 Australia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 82 South Korea plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 83 South Korea plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 84 South Korea plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 85 South Korea plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 86 Thailand plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 87 Thailand plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 88 Thailand plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 89 Thailand plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 90 Latin America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
Table 91 Latin America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 92 Latin America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 93 Latin America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 94 Latin America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 95 Brazil plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 96 Brazil plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 97 Brazil plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 98 Brazil plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 99 Argentina plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 100 Argentina plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 101 Argentina plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 102 Argentina plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 103 MEA plasma fractionation market, by country, 2018 - 2030 (USD Billion)
Table 104 MEA plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 105 MEA plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 106 MEA plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 107 MEA plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 108 South Africa plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 109 South Africa plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 110 South Africa plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 111 South Africa plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 112 Saudi Arabia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 113 Saudi Arabia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 114 Saudi Arabia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 115 Saudi Arabia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 116 UAE plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 117 UAE plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 118 UAE plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 119 UAE plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
Table 120 Kuwait plasma fractionation market, by product, 2018 - 2030 (USD Billion)
Table 121 Kuwait plasma fractionation market, by method, 2018 - 2030 (USD Billion)
Table 122 Kuwait plasma fractionation market, by application, 2018 - 2030 (USD Billion)
Table 123 Kuwait plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Plasma fractionation market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter's five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Plasma fractionation market: Product outlook key takeaways
Fig. 20 Plasma fractionation market: Product movement analysis
Fig. 21 Albumin market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Intravenous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Subcutaneous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 25 Other immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 26 Coagulation Factors market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Factor IX market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 VON WILLEBRAND factor market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 30 Prothrombin complex concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 31 Fibrinogen concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Protease inhibitors market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 35 Plasma fractionation market: Method outlook key takeaways
Fig. 36 Plasma fractionation market: Method movement analysis
Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 Depth Filtration market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Chromatography market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Plasma fractionation market: Application outlook key takeaways
Fig. 42 Plasma fractionation market: Application movement analysis
Fig. 43 Neurology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Hematology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 Oncology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Pulmonology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Plasma fractionation market: End-use outlook key takeaways
Fig. 50 Plasma fractionation market: End-use movement analysis
Fig. 51 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 Regional marketplace outlook, 2024 & 2030 (USD Billion)
Fig. 55 Regional marketplace: Key takeaways
Fig. 56 North America plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 Key country dynamics
Fig. 58 U.S. plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Key country dynamics
Fig. 60 Canada plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Key country dynamics
Fig. 62 Mexico plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Europe plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 64 Key country dynamics
Fig. 65 UK plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Key country dynamics
Fig. 67 Germany plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 68 Key country dynamics
Fig. 69 France plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 70 Key country dynamics
Fig. 71 Spain plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 72 Key country dynamics
Fig. 73 Italy plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 74 Key country dynamics
Fig. 75 Denmark plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 76 Key country dynamics
Fig. 77 Sweden plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 78 Key country dynamics
Fig. 79 Norway plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 80 Asia Pacific plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 81 Key country dynamics
Fig. 82 Japan plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 83 Key country dynamics
Fig. 84 China plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 85 Key country dynamics
Fig. 86 India plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 87 Key country dynamics
Fig. 88 Australia plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 89 Key country dynamics
Fig. 90 South Korea plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 91 Key country dynamics
Fig. 92 Thailand plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 93 Key country dynamics
Fig. 94 Market participant categorization
Fig. 95 Plasma fractionation market position analysis, 2024
Fig. 96 Strategic framework

Product Code: GVR-4-68039-962-8

Plasma Fractionation Market Growth & Trends:

The global plasma fractionation market size is estimated to reach USD 58.24 billion by 2030, registering to grow at a CAGR of 8.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors driving the market growth are the rising prevalence of respiratory illnesses globally, blood-related diseases, and an aging population that is prone to a variety of rare disorders. These are the main drivers of market expansion. In addition, the rise in the prevalence of rare disorders that call for plasma therapy or derivatives also supplemented the market growth.

The global market is also expanding due to the increased use of immunoglobulins as well as alpha-1-antitrypsin in various areas of research around the world. Another important factor for the expansion of the market is the rise in blood collection facilities globally. For instance, as per the WHO, as of May 2022, over 118 million blood donations were collected across the globe, thus increasing the plasma supply gradually. Additionally, supportive government initiatives to raise public awareness about the usage of plasma-derived products also serve as a major driver of the global market's expansion.

Blood plasma transfusions are one of the cutting-edge treatments for COVID-19 infection. For instance, in August 2020, the US Food and Drug Administration (USFDA) granted the convalescent plasma treatment of COVID-19 an emergency use authorization (EUA). Additionally, in February 2021, it published an amended directive for the plasma EUA for COVID-19. As a result, the usage of plasma fractionation technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medications has increased R&D spending, and technological advancements in plasma components such as immune serum globulin, which have advantages such as higher yield, lower cost, and faster throughput, are driving market growth. On the other hand, immunoglobulins generated from plasma are being employed more frequently for a variety of clinical conditions, including autoimmune and inflammatory illnesses. Therapies including Ceruloplasmin, IgA, and Plasmin have received significant funding from the plasma fractionation sector. Additionally, the industry will receive a boost from booming investments in innovation and technology developments that result in efficient and affordable methods for fractionating proteins. thus, propelling the market's growth.

For companies operating market-related businesses, the market offers a lot of opportunities. In addition, the global and regional market participants are actively implementing organic and inorganic development strategies as a result of the market's favorable expansion. As a result, it is anticipated that the market will draw more notable investments during the forecast period. For instance, in January 2022, the eighth plasma collection facility in the Czech Republic was opened by Biotest AG. The national public health authority, SUKL, granted the company an operating license for these centers.

Plasma Fractionation Market Report Highlights:

The immunoglobulins segment dominated the market in terms of revenue share of 63.2% in 2024 and is anticipated to grow at the fastest CAGR of 9.1%. fueled by its widespread use in treating immune deficiencies, autoimmune diseases, and neurological disorders.
The chromatography segment dominated the market and accounted for a 33.7% share in 2024. The utilization of industrial-scale chromatographic fractionation as well as purification techniques for plasma fractionation has increased recently.
The neurology segment held the largest revenue share of 30.0% in 2024, driven by the increasing recognition of plasma-derived therapies for neurological disorders. Conditions such as multiple sclerosis, Guillain-Barre syndrome, and chronic inflammatory demyelinating polyneuropathy are increasingly being treated with therapies like intravenous immunoglobulin (IVIg) and plasmapheresis.
The hospitals and clinics dominated the market with the largest revenue share of 53.4% in 2024 and are expected to grow at the fastest CAGR of 9.0% over the forecast period. This is driven by the increasing demand for plasma-derived therapies in various medical applications.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Method Segment
- 1.2.3. Application Segment
- 1.2.4. End use Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Plasma Fractionation Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growing Demand For Advanced Treatment Options To Boost Market Growth
  - 3.2.1.2. Growing Use Of Immunoglobulins In Various Therapeutic Areas
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Stringent Regulatory Policies
3.3. Plasma Fractionation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Plasma Fractionation Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Plasma Fractionation Market Product Movement Analysis
4.3. Global Plasma Fractionation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Billion)
4.4. Albumin
- 4.4.1. Albumin market estimates and forecasts 2018 to 2030 (USD Billion)
4.5. Immunoglobulins
- 4.5.1. Immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.5.2. Intravenous immunoglobulins
  - 4.5.2.1. Intravenous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.5.3. Subcutaneous immunoglobulins
  - 4.5.3.1. Subcutaneous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.5.4. Other immunoglobulins
  - 4.5.4.1. Other immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
4.6. Coagulation Factors
- 4.6.1. Coagulation factors market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.6.2. Factor VIII
  - 4.6.2.1. Factor VIII market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.6.3. Factor IX
  - 4.6.3.1. Factor IX market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.6.4. VON WILLEBRAND factor
  - 4.6.4.1. VON WILLEBRAND factor market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.6.5. Prothrombin complex concentrates
  - 4.6.5.1. Prothrombin complex concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.6.6. Fibrinogen concentrates
  - 4.6.6.1. Fibrinogen concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.6.7. Others
  - 4.6.7.1. Others factor market estimates and forecasts 2018 to 2030 (USD Billion)
4.7. Protease inhibitors
- 4.7.1. Protease inhibitors market estimates and forecasts 2018 to 2030 (USD Billion)
4.8. Others
- 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Plasma Fractionation Market: Method Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Plasma Fractionation Market Method Movement Analysis
5.3. Global Plasma Fractionation Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Billion)
5.4. Centrifugation
- 5.4.1. Centrifugation market estimates and forecasts 2018 to 2030 (USD Billion)
5.5. Depth Filtration
- 5.5.1. Depth filtration market estimates and forecasts 2018 to 2030 (USD Billion)
5.6. Chromatography
- 5.6.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Billion)
5.7. Others
- 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Plasma Fractionation Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Plasma Fractionation Market Application Movement Analysis
6.3. Global Plasma Fractionation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
6.4. Neurology
- 6.4.1. Neurology market estimates and forecasts 2018 to 2030 (USD Billion)
6.5. Hematology
- 6.5.1. Hematology market estimates and forecasts 2018 to 2030 (USD Billion)
6.6. Oncology
- 6.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Billion)
6.7. Immunology
- 6.7.1. Immunology market estimates and forecasts 2018 to 2030 (USD Billion)
6.8. Pulmonology
- 6.8.1. Pulmonology market estimates and forecasts 2018 to 2030 (USD Billion)
6.9. Others
- 6.9.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Plasma Fractionation Market: End-use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Plasma Fractionation Market End-use Movement Analysis
7.3. Global Plasma Fractionation Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Billion)
7.4. Hospitals & Clinics
- 7.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Billion)
7.5. Clinical Research
- 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Billion)
7.6. Others
- 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Plasma Fractionation Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Competitive scenario
  - 8.4.1.3. Regulatory framework
  - 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.4.2. Canada
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. Regulatory framework
  - 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.4.3. Mexico
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Regulatory framework
  - 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive scenario
  - 8.5.1.3. Regulatory framework
  - 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Regulatory framework
  - 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Regulatory framework
  - 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. Regulatory framework
  - 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Regulatory framework
  - 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.6. Denmark
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Competitive scenario
  - 8.5.7.3. Regulatory framework
  - 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.8. Norway
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Competitive scenario
  - 8.5.8.3. Regulatory framework
  - 8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive scenario
  - 8.6.1.3. Regulatory framework
  - 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.2. China
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Regulatory framework
  - 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.3. India
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. Regulatory framework
  - 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.4. Australia
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. Regulatory framework
  - 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. Regulatory framework
  - 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. Regulatory framework
  - 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive scenario
  - 8.7.1.3. Regulatory framework
  - 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.7.2. Argentina
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Regulatory framework
  - 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Competitive scenario
  - 8.8.1.3. Regulatory framework
  - 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Competitive scenario
  - 8.8.3.3. Regulatory framework
  - 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Competitive scenario
  - 8.8.4.3. Regulatory framework
  - 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
- 9.4.1. Grifols S.A.
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. CSL Limited
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Takeda Pharmaceutical Company Limited
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Octapharma AG
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Kedrion S.p.A
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. LFB S.A.
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Biotest AG
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Sanquin
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Bio Products Laboratory Ltd.
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. Intas Pharmaceuticals Ltd
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives

血漿分画の市場規模、シェア、動向分析レポート：製品別、方法別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

血漿分画市場の成長と動向：

血漿分画市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章血漿分画市場の変数、動向、範囲

第4章血漿分画市場：製品別推定・動向分析

第5章血漿分画市場：方法別推定・動向分析

第6章血漿分画市場：用途別推定・動向分析

第7章血漿分画市場：最終用途別推定・動向分析

第8章血漿分画市場：地域別推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Plasma Fractionation Market Growth & Trends:

Plasma Fractionation Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Plasma Fractionation Market Variables, Trends & Scope

Chapter 4. Plasma Fractionation Market: Product Estimates & Trend Analysis

Chapter 5. Plasma Fractionation Market: Method Estimates & Trend Analysis

Chapter 6. Plasma Fractionation Market: Application Estimates & Trend Analysis

Chapter 7. Plasma Fractionation Market: End-use Estimates & Trend Analysis

Chapter 8. Plasma Fractionation Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

血漿分画の市場規模、シェア、動向分析レポート：製品別、方法別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

血漿分画市場の成長と動向：

血漿分画市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血漿分画市場の変数、動向、範囲

第4章 血漿分画市場：製品別推定・動向分析

第5章 血漿分画市場：方法別推定・動向分析

第6章 血漿分画市場：用途別推定・動向分析

第7章 血漿分画市場：最終用途別推定・動向分析

第8章 血漿分画市場：地域別推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Plasma Fractionation Market Growth & Trends:

Plasma Fractionation Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Plasma Fractionation Market Variables, Trends & Scope

Chapter 4. Plasma Fractionation Market: Product Estimates & Trend Analysis

Chapter 5. Plasma Fractionation Market: Method Estimates & Trend Analysis

Chapter 6. Plasma Fractionation Market: Application Estimates & Trend Analysis

Chapter 7. Plasma Fractionation Market: End-use Estimates & Trend Analysis

Chapter 8. Plasma Fractionation Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章血漿分画市場の変数、動向、範囲

第4章血漿分画市場：製品別推定・動向分析

第5章血漿分画市場：方法別推定・動向分析

第6章血漿分画市場：用途別推定・動向分析

第7章血漿分画市場：最終用途別推定・動向分析

第8章血漿分画市場：地域別推定・動向分析

第9章競合情勢